Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery
- PMID: 18458872
- DOI: 10.1007/s00125-008-1007-y
Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery
Abstract
Aims/hypothesis: We have previously demonstrated that type 2 diabetes resolves after bariatric surgery. To study the role of NEFA in the prompt normalisation of beta cell glucose sensitivity, insulin secretion and beta cell glucose and lipid metabolism were investigated by a model of nutrient-stimulated insulin secretion using a multiple-meal test.
Methods: Hourly glucose, C-peptide and NEFA were measured in nine morbidly obese, type 2 diabetic patients before and 1 week after bariatric surgery and in six matched healthy volunteers over 24 h. A mathematical model of glucose-NEFA comodulation of insulin secretion rate (ISR) was used to compute ISR and beta-oxidation. Insulin sensitivity was measured by an OGTT minimal model.
Results: Beta cell sensitivity to glucose and NEFA was doubled after surgery, while the 24 h insulin secretion decreased from 277.1 +/- 144.4 to 198.0 +/- 107.6 nmol/m(2) (p < 0.02). Insulin sensitivity was restored. The beta-oxidation rate of beta cells was completely normalised (from 0.032 +/- 0.012 x 10(-12) to 0.103 +/- 0.031 x 10(-12) mmol/min per cell, p < 0.005). The best predictor of beta cell function improvement was the duration of diabetes.
Conclusions/interpretation: Bariatric surgery in type 2 diabetes restores beta-oxidation in beta cells, doubles glucose-NEFA sensitivity and reverses diabetes. It is likely that ISR is reduced to match insulin-sensitivity normalisation, in spite of no significant reduction in NEFA levels. We hypothesise that insulin sensitivity normalisation might appear as a consequence of nutrient exclusion from proximal intestinal transit, and that secondarily the need for insulin secretion diminishes. The insulin sensitivity increase is much higher than usually obtained by insulin-sensitising agents and is independent of weight changes.
Comment in
-
Enhancement of the incretin pathway in response to bariatric surgery is important for restoration of beta cell function.Diabetologia. 2009 Feb;52(2):374-5; author reply 376-7. doi: 10.1007/s00125-008-1230-6. Epub 2008 Nov 27. Diabetologia. 2009. PMID: 19037625 No abstract available.
Similar articles
-
NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test.Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1890-8. doi: 10.1152/ajpendo.00563.2006. Epub 2007 Mar 6. Am J Physiol Endocrinol Metab. 2007. PMID: 17341546
-
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.Diabetologia. 2018 Aug;61(8):1829-1837. doi: 10.1007/s00125-018-4633-z. Epub 2018 May 7. Diabetologia. 2018. PMID: 29732475
-
Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.Obes Surg. 2016 Aug;26(8):1924-31. doi: 10.1007/s11695-015-2038-3. Obes Surg. 2016. PMID: 26729277 Clinical Trial.
-
Insulin sensitivity and secretion modifications after bariatric surgery.J Endocrinol Invest. 2012 Jul;35(7):692-8. doi: 10.3275/8470. Epub 2012 Jun 25. J Endocrinol Invest. 2012. PMID: 22732257 Review.
-
Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.Diabetes Metab. 2009 Dec;35(6 Pt 2):518-23. doi: 10.1016/S1262-3636(09)73459-7. Diabetes Metab. 2009. PMID: 20152737 Review.
Cited by
-
Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost.J Gastrointest Surg. 2010 Jan;14(1):15-23. doi: 10.1007/s11605-009-1060-y. Epub 2009 Oct 17. J Gastrointest Surg. 2010. PMID: 19838759 Free PMC article. Clinical Trial.
-
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.Obes Surg. 2010 Jun;20(6):776-90. doi: 10.1007/s11695-010-0113-3. Obes Surg. 2010. PMID: 20333558 Review.
-
The effect of gastrointestinal surgery on insulin resistance and insulin secretion.Curr Atheroscler Rep. 2012 Dec;14(6):624-30. doi: 10.1007/s11883-012-0284-6. Curr Atheroscler Rep. 2012. PMID: 23001770 Review.
-
Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.Diabetes Care. 2014;37(3):780-8. doi: 10.2337/dc13-1879. Epub 2013 Nov 5. Diabetes Care. 2014. PMID: 24194506 Free PMC article. Clinical Trial.
-
Enhancement of the incretin pathway in response to bariatric surgery is important for restoration of beta cell function.Diabetologia. 2009 Feb;52(2):374-5; author reply 376-7. doi: 10.1007/s00125-008-1230-6. Epub 2008 Nov 27. Diabetologia. 2009. PMID: 19037625 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical